Clinical Trials Market to Reach Around USD77.20 Billion By 2026 | TechSci Research
According to TechSci Research report, “Global Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune/Inflammation, Oncology, CNS, Diabetes, Cardiovascular, Others), By Type (Pharmaceutical Trials Vs Medical Device Trials), By End User (Clinical Research Organizations, Pharmaceutical and Biotechnological Companies, Clinical Testing Laboratories, Others), By Company, By Region, Forecast & Opportunities, 2026”, the global clinical trials market was valued at around USD51.25 billion in 2020 and is anticipated to reach USD77.20 billion in 2026 by registering a growing CAGR of 7.10%. Key factors propelling the growth of the global clinical trials market include growing prevalence of chronic diseases around the world and increasing need for personalized and orphan drugs. The demand for new medical equipment and increase in the number of biologics are further anticipated to accelerate the growth of this market. Additionally, the occurrence of tropical and infectious diseases such as COVID-19 has also led to extensive clinical trials around the world in order to find the suitable treatment and vaccine. With increasing investments in R&D activities and growing focus of governments to find a cure for deadly diseases such as coronavirus, the global clinical trials market is expected to grow substantially through 2026.
Moreover, increasing prevalence of nеurоlоgісаl dіѕеаѕеѕ such as Раrkіnѕоn’ѕ, dерrеѕѕіоn, Аlzhеіmеr’s and еріlерѕу coupled with rising geriatric population is also supporting the growth of global clinical trials market. In addition to this, the digitization of сlіnісаl trіаlѕ, in an effort to еnhаnсe рrоduсtіvіtу and gather data from multірlе ѕоurсеѕ is anticipated to propel the market growth in the coming years. Furthermore, rising аdорtіоn of virtual сlіnісаl trіаlѕ that facilitate efficient and safe data gathering from раrtісіраntѕ without the requirement for trаvеlіng tо thе lаb оr hospital is augmenting the growth of the global clinical trials market.
Browse 148 Figures spread through 110 Pages and an in-depth TOC on "Global Clinical Trials Market"
The global clinical trials market is segmented based on phase, study design, indication, type, end user and region. Based on phase, the market can be segmented into phase I, phase II, phase III and phase IV. Among these, the phase III segment dominated the global clinical trials market in 2020 by holding 44.36% market share as they involve huge subjects and are the most expensive out of all four phases. However, the phase II segment is expected to register the highest CAGR during the forecast period as it is conducted for safety and efficiency. Also, there are various therapeutic drug and vaccine trials currently undergoing phase II clinical trials for the treatment of coronavirus.
Based on study design, the global clinical trials market can be segmented into interventional, observational and expanded access. Among them, the interventional design segment accounted for the largest market share in 2020. They are further expected to dominate the global market in terms of revenue during the forecast period. Interventional treatment studies are one of the most prominent methods used in clinical trials and are mainly used for drug or biologics, clinical procedure, behavioral and device intervention studies.
Major players operating in the global clinical trials market include Еlі Lіllу аnd Соmраnу, Ѕun Рhаrmасеutісаl Іnduѕtrіеѕ Ltd., Nоvо Nоrdіѕk А/Ѕ, Рfіzеr Іnс., GlaxoSmithKline plc, ІСОN рlс, Pharmaceutical Product Development LLC, Ноffmаnn-Lа Rосhе Ltd., ІQVІА Ноldіngѕ Іnс., Covance Inc., Syneos Health Inc., PRA Health Sciences Inc., Medpace Holdings, Inc., WuXi Apptec Company Ltd., Thermo Fisher Scientific Inc. The companies are engaging in mergers and acquisitions along with new product launches to strengthen their position in the global market.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5082
Customers can also request for 10% free customization on this report.
“North America accounted for the largest market share in global clinical trials market in 2020 owing to increasing adoption of new and advanced healthcare technologies in the region. The region is further expected to dominate the global market during the forecast period as governments in countries such as the United States and Canada are providing favorable support and infrastructure regarding clinical trials. However, Asia-Pacific is expected to register the fastest CAGR through 2026 owing to the increasing number of biotechnological firms undergoing COVID-19 vaccine trials,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune/Inflammation, Oncology, CNS, Diabetes, Cardiovascular, Others), By Type (Pharmaceutical Trials Vs Medical Device Trials), By End User (Clinical Research Organizations, Pharmaceutical and Biotechnological Companies, Clinical Testing Laboratories, Others), By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of global clinical trials market and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in the global clinical trials market.
Browse Related Reports:
Global Coronavirus Vaccine Market By Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, MERS-CoV, SARS-CoV-2, Others), By Vaccine Type (Inactivated Coronavirus Vaccine, Live Attenuated Coronavirus Vaccine, S-Protein Based Coronavirus Vaccine), By Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Oral, Intramuscular, Subcutaneous), By Patient Type (Pediatric v/s Adult), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Forecast & Opportunities, 2025
India Coronavirus Testing Kits Market By Type of Test (Molecular v/s Serology), By Use (Disposable v/s Reusable), By Full Test Time (5 Minutes, 5- 15 Minutes, 15-60Minutes, 1 Hours- 5 Hours, 5 Hours-12Hours, 12 Hours-24Hours, More Than 1 Days), By Technology (RT-PCR, IgG, IgM ELISA Test, Microneutralization Assays), By Specimen Type (Nose & Throat Swab, Blood, Sputum, Nasal Aspirate), By Mobility (Portable v/s Stationary), By End Use (Hospitals, Clinics, Public Health Labs, Private or Commercial Labs, Physician Labs, Research Institutes, Others), By Region, Forecast & Opportunities, 2025
About TechSci Research
TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017
For More Market Research Blogs Visit: https://techsciblog.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinical Trials Market to Reach Around USD77.20 Billion By 2026 | TechSci Research here
News-ID: 2275587 • Views: 251
More Releases from TechSci Research Pvt Ltd
United States Patient at Home Testing Kits Market to Grow with a Double Digit CA …
Technologically advanced medical devices are driving the growth of United States Patient At Home Testing Kits Market, in the forecast period. According to TechSci report on, “United States Patient At Home Testing Kits Market By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, COVID-19 Testing, Urine analysis, Others) By Sample (Blood, Urine, Saliva, Swab, Others) By Usage (Reusable v/s Disposable) By Distribution Channel (Retail Stores, Hypermarket/Supermarket, E-Commerce) By
United States Mobile C-Arm Market to Grow with a Double Digit CAGR until 2026 | …
Advancing technology in healthcare industry is driving the growth of United States Mobile C-Arm Market, in the forecast period. According to TechSci report on, “United States Mobile C-Arm Market By Type (Full Size C-arm v/s Mini Size C-arm) By Technology (Flat Panel v/s Image Intensifiers) By Application (Orthopedics and Trauma, Cardiovascular, Urology, Gastroenterology, Neurology, Others) By End Users (Hospitals, Specialty Clinics, Ambulatory Surgical Clinics) By Region, Competition Forecast & Opportunities, 2026”,
United States Human Insulin Market to Grow with Increasing Diabetics until 2026 …
Surge in diabetic patients is driving the growth of United States Human Insulin Market, in the forecast period. According to TechSci report on, “United States Human Insulin Market By Indication (Type 1 Diabetes v/s Type 2 Diabetes) By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection) By Type (Basal, Bolus, Pre-Mixed, Biosimilar, Traditional) By Onset Time (Rapid Acting, Short Acting, Intermediate Acting, Long Lasting, Others) By Brand (Lantus, Humulin R, Novolin
United States Stent Market to Grow with a Double Digit CAGR until 2026 | TechSci …
Increasing vision aesthetics is driving the growth of United States Stent Market, in the forecast period. According to TechSci report on, “United States Stent Market By Material Type (Silicone hydrogel, Hydrogel, Gas permeable, Others) By Design (Spherical, Toric, Multifocal, Others) By Wear Type (Disposable v/s Reusable) By Application (Corrective, Therapeutic, Cosmetic, Others) By Distribution Channel (Retail Stores, Hospitals & Clinics, Online) By Region, Competition Forecast & Opportunities, 2026”, United States stent
More Releases for Clinical
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Nutrition Conference 2018
Clinical nutrition is essential for patients in healthcare to deal with sickness, injuries, surgery and for proper recovery. It helps in preventing malnutrition, restoring body tissue and boosting energy and immunity in the body. It can be provided with a proper diet plan and feeding the patient with essential foods that revive the patient’s body the patient can also be given healthy supplements for proteins, vitamins etc. The preferred route
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
Europe Clinical Nutrition Market
According to the report “Europe Clinical Nutrition Market,” published by Market Data Forecast, the global market is projected to reach USD 12.45 billion by 2021 from USD 9.65 billion in 2016, at a CAGR of 5.29% from 2016 to 2021. Clinical nutrition is the practice of analysing if a person is consuming an adequate amount of nutrients for good health. A clinical nutritionist is concerned with how nutrients in food are